Next Article in Journal
Pharmacological Aspects of Vipera xantina palestinae Venom
Next Article in Special Issue
Inhibitors of the Cellular Trafficking of Ricin
Previous Article in Journal
Molecular Conversion of Muscarinic Acetylcholine Receptor M5 to Muscarinic Toxin 7 (MT7)-Binding Protein
Previous Article in Special Issue
Understanding Ricin from a Defensive Viewpoint
Toxins 2011, 3(11), 1405-1419; doi:10.3390/toxins3111405

Llama-Derived Single Domain Antibodies Specific for Abrus Agglutinin

1,* , 1
, 1
, 2
, 1
, 3
, 4
, 4
, 5
, 5
 and 6
Received: 2 September 2011 / Revised: 23 October 2011 / Accepted: 1 November 2011 / Published: 11 November 2011
(This article belongs to the Special Issue Ricin Toxin)
View Full-Text   |   Download PDF [490 KB, updated 25 November 2011; original version uploaded 11 November 2011]   |   Browse Figures
Abstract: Llama derived single domain antibodies (sdAb), the recombinantly expressed variable heavy domains from the unique heavy-chain only antibodies of camelids, were isolated from a library derived from llamas immunized with a commercial abrin toxoid preparation. Abrin is a potent toxin similar to ricin in structure, sequence and mechanism of action. The selected sdAb were evaluated for their ability to bind to commercial abrin as well as abrax (a recombinant abrin A-chain), purified abrin fractions, Abrus agglutinin (a protein related to abrin but with lower toxicity), ricin, and unrelated proteins. Isolated sdAb were also evaluated for their ability to refold after heat denaturation and ability to be used in sandwich assays as both capture and reporter elements. The best binders were specific for the Abrus agglutinin, showing minimal binding to purified abrin fractions or unrelated proteins. These binders had sub nM affinities and regained most of their secondary structure after heating to 95 °C. They functioned well in sandwich assays. Through gel analysis and the behavior of anti-abrin monoclonal antibodies, we determined that the commercial toxoid preparation used for the original immunizations contained a high percentage of Abrus agglutinin, explaining the selection of Abrus agglutinin binders. Used in conjunction with anti-abrin monoclonal and polyclonal antibodies, these reagents can fill a role to discriminate between the highly toxic abrin and the related, but much less toxic, Abrus agglutinin and distinguish between different crude preparations.
Keywords: abrin; single domain antibody; reversible refolding abrin; single domain antibody; reversible refolding
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Goldman, E.R.; Anderson, G.P.; Zabetakis, D.; Walper, S.; Liu, J.L.; Bernstein, R.; Calm, A.; Carney, J.P.; O’Brien, T.W.; Walker, J.L.; Garber, E.A.E. Llama-Derived Single Domain Antibodies Specific for Abrus Agglutinin. Toxins 2011, 3, 1405-1419.

AMA Style

Goldman ER, Anderson GP, Zabetakis D, Walper S, Liu JL, Bernstein R, Calm A, Carney JP, O’Brien TW, Walker JL, Garber EAE. Llama-Derived Single Domain Antibodies Specific for Abrus Agglutinin. Toxins. 2011; 3(11):1405-1419.

Chicago/Turabian Style

Goldman, Ellen R.; Anderson, George P.; Zabetakis, Dan; Walper, Scott; Liu, Jinny L.; Bernstein, Rachael; Calm, Alena; Carney, James P.; O’Brien, Thomas W.; Walker, Jennifer L.; Garber, Eric A. E. 2011. "Llama-Derived Single Domain Antibodies Specific for Abrus Agglutinin." Toxins 3, no. 11: 1405-1419.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert